Halozyme Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
71,502.60
135,623.00
108,339.00
204,981.00
469,214.00
354,526
Total Accounts Receivable
9,097.10
9,149.00
32,410.00
15,680.00
22,133.00
30,005
Inventories
6,170.00
6,406.00
9,489.00
14,623.00
5,146.00
22,625
Other Current Assets
8,425.70
10,143.00
21,534.00
21,248.00
13,879.00
20,693
Total Current Assets
95,195.40
161,321.00
171,772.00
256,532.00
510,372.00
427,849
Net Property, Plant & Equipment
3,421.50
2,951.00
3,943.00
4,264.00
3,520.00
7,465
Total Investments and Advances
500.00
500.00
500.00
500.00
500.00
500
Other Assets
2,675.70
1,205.00
5,574.00
219.00
5,553.00
4,434
Total Assets
101,792.60
165,977.00
181,789.00
261,515.00
519,945.00
440,248
ST Debt & Current Portion LT Debt
-
-
21,862.00
17,393.00
77,211.00
Accounts Payable
3,134.80
3,003.00
4,499.00
3,578.00
7,948.00
Other Current Liabilities
22,318.30
21,328.00
36,096.00
33,614.00
46,169.00
Total Current Liabilities
25,453.00
24,331.00
62,457.00
54,585.00
131,328.00
Long-Term Debt
49,771.70
49,860.00
27,971.00
199,228.00
125,140.00
Other Liabilities
46,558.50
50,434.00
48,362.00
40,183.00
55,111.00
Total Liabilities
121,783.30
124,625.00
138,790.00
293,996.00
311,579.00
Common Equity (Total)
19,990.70
41,352.00
42,999.00
32,481.00
208,366.00
Total Shareholders' Equity
19,990.70
41,352.00
42,999.00
32,481.00
208,366.00
Total Equity
19,990.70
41,352.00
42,999.00
32,481.00
208,366.00
Liabilities & Shareholders' Equity
101,792.60
165,977.00
181,789.00
261,515.00
519,945.00
About Halozyme Therapeutics
View Profile
